A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors

Conditions:   Metastatic Cancer;   Melanoma Cancer;   Lung Cancer;   Bladder Cancer;   Renal Cancer;   Head/Neck Cancers
Interventions:   Radiation: Stereotactic Body Radiotherapy;   Biological: checkpoint inhibitor
Sponsor:   Memorial Sloan Kettering Cancer Center
Recruiting

https://ift.tt/2IxYD7A